Skip to main content
logo
bioXXmed AG (FRA:T5O)
Germany flag Germany · Delayed Price · Currency is EUR
0.9500
+0.1000 (11.76%)
At close: Aug 26, 2026

bioXXmed AG Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
0015618
Market Cap Growth
-11.80%-95.56%-86.90%-9.91%-69.02%-70.98%
Enterprise Value
0014218
Last Close Price
0.850.116.5541.0145.52185.86

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-14.7214.7214.7214.7214.72
PS Ratio
13.811.79192.67295.19466.16412.49
PB Ratio
-231085.00-29905.002.1110.930.271.03
P/TBV Ratio
--2.1110.930.271.03

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
24.655.25167.63233.04165.61394.46

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
-385000.00-385000.00-0.02-0.01
Net Debt / Equity Ratio
-181332.00-181332.00-0.80-1.29-0.090.01
Net Debt / EBITDA Ratio
-0.67-0.670.290.752.25-0.08
Net Debt / FCF Ratio
-0.54-0.540.280.832.01-
Asset Turnover
0.040.040.010.000.000.00
Quick Ratio
234.64234.643.156.6013.830.16
Current Ratio
356.12356.124.047.3614.230.38
Return on Equity (ROE)
-229.36%-229.36%-252.84%-191.41%-4.23%-20.40%
Return on Assets (ROA)
-35.44%-35.44%-93.01%-4.52%-2.58%-4.84%
Return on Capital Employed (ROCE)
-57.90%-57.90%-214.30%-136.40%-3.80%-8.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-158.12%-1221.84%-148.13%-407.77%-14.55%-22.05%
FCF Yield
-144.97%-1120.21%-136.11%-14.21%-16.03%-
Buyback Yield / Dilution
-0.00%-164.59%--27.54%-